Targeting the immune system in intracerebral hemorrhage

JAMA Neurol. 2014 Sep;71(9):1083-4. doi: 10.1001/jamaneurol.2014.1653.

Authors

Kevin N Sheth¹, Jonathan Rosand²

Affiliations

¹ Division of Neurocritical Care and Emergency Neurology, Department of Neurology, Yale University School of Medicine, New Haven, Connecticut.
² Division of Neurocritical Care and Emergency Neurology, Center for Human Genetic Research, Massachusetts General Hospital, Boston.

PMID: 25004375
DOI: 10.1001/jamaneurol.2014.1653

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Cerebral Hemorrhage / drug therapy*
Female
Fingolimod Hydrochloride
Humans
Immunosuppressive Agents / pharmacology*
Male
Propylene Glycols / pharmacology*
Sphingosine / analogs & derivatives*
Sphingosine / pharmacology

Substances

Immunosuppressive Agents
Propylene Glycols
Fingolimod Hydrochloride
Sphingosine